These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24664420)

  • 1. Direct T cell activation via CD40 ligand generates high avidity CD8+ T cells capable of breaking immunological tolerance for the control of tumors.
    Soong RS; Song L; Trieu J; Lee SY; He L; Tsai YC; Wu TC; Hung CF
    PLoS One; 2014; 9(3):e93162. PubMed ID: 24664420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines.
    Ceglia V; Zurawski S; Montes M; Kroll M; Bouteau A; Wang Z; Ellis J; Igyártó BZ; Lévy Y; Zurawski G
    Front Immunol; 2021; 12():786144. PubMed ID: 35095862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel T cell-based vaccine capable of stimulating long-term functional CTL memory against B16 melanoma via CD40L signaling.
    Xie Y; Wang L; Freywald A; Qureshi M; Chen Y; Xiang J
    Cell Mol Immunol; 2013 Jan; 10(1):72-7. PubMed ID: 23042534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xenogeneic human p53 DNA vaccination by electroporation breaks immune tolerance to control murine tumors expressing mouse p53.
    Soong RS; Trieu J; Lee SY; He L; Tsai YC; Wu TC; Hung CF
    PLoS One; 2013; 8(2):e56912. PubMed ID: 23457640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
    Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
    Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-trimeric fusion of CD40L and gp100 tumor antigen activates dendritic cells and enhances survival in a B16-F10 melanoma DNA vaccine model.
    Gupta S; Termini JM; Rivas Y; Otero M; Raffa FN; Bhat V; Farooq A; Stone GW
    Vaccine; 2015 Sep; 33(38):4798-806. PubMed ID: 26241951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40 ligand promotes priming of fully potent antitumor CD4(+) T cells in draining lymph nodes in the presence of apoptotic tumor cells.
    Fujita N; Kagamu H; Yoshizawa H; Itoh K; Kuriyama H; Matsumoto N; Ishiguro T; Tanaka J; Suzuki E; Hamada H; Gejyo F
    J Immunol; 2001 Nov; 167(10):5678-88. PubMed ID: 11698440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of tolerogenic dendritic cells in the tumor draining lymph nodes by CD8+ T cells engineered to express CD40 ligand.
    Higham EM; Wittrup KD; Chen J
    J Immunol; 2010 Apr; 184(7):3394-400. PubMed ID: 20200275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag.
    Gupta S; Termini JM; Raffa FN; Williams CA; Kornbluth RS; Stone GW
    J Virol; 2014 Feb; 88(3):1492-501. PubMed ID: 24227853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
    Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
    Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced protective immunity derived from dendritic cells with phagocytosis of CD40 ligand transgene-engineered apoptotic tumor cells via increased dendritic cell maturation.
    Parameswaran S; Khalil M; Ahmed KA; Sharma RK; Xiang J
    Tumori; 2015; 101(6):637-43. PubMed ID: 25983089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-12-mediated STAT4 signaling and TCR signal strength cooperate in the induction of CD40L in human and mouse CD8+ T cells.
    Stark R; Hartung A; Zehn D; Frentsch M; Thiel A
    Eur J Immunol; 2013 Jun; 43(6):1511-7. PubMed ID: 23765345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40-CD40 ligand interaction between dendritic cells and CD8+ T cells is needed to stimulate maximal T cell responses in the absence of CD4+ T cell help.
    Hernandez MG; Shen L; Rock KL
    J Immunol; 2007 Mar; 178(5):2844-52. PubMed ID: 17312128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic expression of CD40 ligand produces an in vivo antitumor immune response against both CD40(+) and CD40(-) plasmacytoma cells.
    Dotti G; Savoldo B; Yotnda P; Rill D; Brenner MK
    Blood; 2002 Jul; 100(1):200-7. PubMed ID: 12070028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40 ligand stimulation affects the number and memory phenotypes of human peripheral CD8
    Choi H; Lee HJ; Sohn HJ; Kim TG
    BMC Immunol; 2023 Jun; 24(1):15. PubMed ID: 37391734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentivector prime and vaccinia virus vector boost generate high-quality CD8 memory T cells and prevent autochthonous mouse melanoma.
    Xiao H; Peng Y; Hong Y; Liu Y; Guo ZS; Bartlett DL; Fu N; He Y
    J Immunol; 2011 Aug; 187(4):1788-96. PubMed ID: 21746967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor responses induced by transgenic expression of CD40 ligand.
    Grossmann ME; Brown MP; Brenner MK
    Hum Gene Ther; 1997 Nov; 8(16):1935-43. PubMed ID: 9382959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential requirements of CD4(+) T-cell signals for effector cytotoxic T-lymphocyte (CTL) priming and functional memory CTL development at higher CD8(+) T-cell precursor frequency.
    Umeshappa CS; Nanjundappa RH; Xie Y; Freywald A; Xu Q; Xiang J
    Immunology; 2013 Apr; 138(4):298-306. PubMed ID: 23113741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.
    Schoenberger SP; Toes RE; van der Voort EI; Offringa R; Melief CJ
    Nature; 1998 Jun; 393(6684):480-3. PubMed ID: 9624005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic CD40 signaling on APCs and CD8 T cells drives efficient CD8 response and memory differentiation.
    Meunier S; Rapetti L; Beziaud L; Pontoux C; Legrand A; Tanchot C
    J Leukoc Biol; 2012 Jun; 91(6):859-69. PubMed ID: 22241832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.